C07K 14/78
Connective tissue peptides
Official title: Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
C07K14/78 (Connective tissue peptides) appears on 2,092 US grants and 2,623 published applications in this corpus.
Search patents in C07K- Granted patents
- 2,092
- Published applications
- 2,623
- Assignees
- 1,324
- Inventors
- 5,302
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 4 | 0 |
| 1980 | 4 | 0 |
| 1981 | 4 | 0 |
| 1982 | 5 | 0 |
| 1983 | 7 | 0 |
| 1984 | 10 | 0 |
| 1985 | 4 | 0 |
| 1986 | 6 | 0 |
| 1987 | 8 | 0 |
| 1988 | 3 | 0 |
| 1989 | 7 | 0 |
| 1990 | 6 | 0 |
| 1991 | 14 | 0 |
| 1992 | 30 | 0 |
| 1993 | 32 | 0 |
| 1994 | 32 | 0 |
| 1995 | 38 | 0 |
| 1996 | 38 | 0 |
| 1997 | 70 | 0 |
| 1998 | 109 | 0 |
| 1999 | 70 | 0 |
| 2000 | 52 | 0 |
| 2001 | 39 | 9 |
| 2002 | 42 | 71 |
| 2003 | 37 | 105 |
| 2004 | 40 | 84 |
| 2005 | 34 | 80 |
| 2006 | 31 | 59 |
| 2007 | 40 | 59 |
| 2008 | 27 | 75 |
| 2009 | 32 | 81 |
| 2010 | 56 | 92 |
| 2011 | 39 | 75 |
| 2012 | 54 | 86 |
| 2013 | 65 | 124 |
| 2014 | 65 | 108 |
| 2015 | 84 | 98 |
| 2016 | 65 | 106 |
| 2017 | 66 | 103 |
| 2018 | 72 | 130 |
| 2019 | 95 | 160 |
| 2020 | 91 | 144 |
| 2021 | 101 | 137 |
| 2022 | 80 | 130 |
| 2023 | 79 | 143 |
| 2024 | 65 | 144 |
| 2025 | 79 | 132 |
| 2026 | 56 | 88 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Biodegradable textile fibers with inherent color and properties18 Aug 2026US 12,709,640 B2The Trustees of Columbia University in the City of New York
- Protein-based purification matrices and methods of using the same28 Jul 2026US 12,692,483 B2Donaldson Company, Inc.
- Miniaturized dystrophins and uses thereof14 Jul 2026US 12,680,108 B2Bristol-Myers Squibb Company
- Collagen-based meniscus implants7 Jul 2026US 12,673,135 B2Collagen Matrix, Inc.
- Recombinant adeno-associated virus products and methods for treating dystroglycanopathies and laminin-deficient muscular dystrophies30 Jun 2026US 12,668,617 B2Research Institute At Nationwide Children's Hospital
- Method for preparing a telechelic polymer from a peptide8 Oct 2026US 2026/0308199 A1matrihealth GmbH
- Collagen production method8 Oct 2026US 2026/0308236 A1UniBio Corporation
- Dual transporters and methods of use8 Oct 2026US 2026/0308269 A1Denali Therapeutics Inc.
- Serum albumin-binding fibronectin type iii domains1 Oct 2026US 2026/0297168 A1Bristol-Myers Squibb Company
- Synthetic notch receptors for use in customized spatial control of multiple gene expressions and uses thereof1 Oct 2026US 2026/0297539 A1The Regents of the University of California
Most cited
By later US patents
- Collagen-polymer conjugates778US 5,162,430 ACollagen Corporation · 1992
- Biologically inert, biocompatible-polymer conjugates521US 5,324,775 ACollagen Corporation · 1994
- Collagen-polymer conjugates471US 5,328,955 ACollagen Corporation · 1994
- Injectable cross-linked collagen implant material440US 4,582,640 ACollagen Corporation · 1986
- Collagen implant material and method for augmenting soft tissue364US 4,424,208 ACollagen Corporation · 1984